EBA
WST icon

Eagle Bay Advisors’s West Pharmaceutical WST Stock Holding History

Eagle Bay Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-458
Closed -$150K – 956
2024
Q4 		$150K Sell
458
-13
-3% -$4.09K 0.09% 141
2024
Q3 		$141K Sell
471
-29
-6% -$8.88K 0.05% 222
2024
Q2 		$165K Sell
500
-77
-13% -$27.2K 0.1% 138
2024
Q1 		$228K Sell
577
-270
-32% -$99.9K 0.14% 117
2023
Q4 		$298K Sell
847
-239
-22% -$84.6K 0.19% 90
2023
Q3 		$407K Buy
1,086
+197
+22% +$76.2K 0.19% 79
2023
Q2 		$340K Sell
889
-49
-5% -$17.5K 0.19% 77
2023
Q1 		$325K Sell
938
-104
-10% -$30.4K 0.18% 85
2022
Q4 		$245K Buy
1,042
+490
+89% +$116K 0.14% 111
2022
Q3 		$136K Sell
552
-300
-35% -$91.4K 0.08% 158
2022
Q2 		$258K Buy
852
+310
+57% +$101K 0.16% 105
2022
Q1 		$222K Sell
542
-80
-13% -$31.3K 0.18% 89
2021
Q4 		$292K Buy
622
+58
+10% +$25K 0.19% 80
2021
Q3 		$239K Buy
564
+161
+40% +$67.9K 0.13% 116
2021
Q2 		$145K Buy
+403
New +$133K 0.12% 114

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Eagle Bay Advisors's WST Position: Q1 2025 in Review

Eagle Bay Advisors sold out of West Pharmaceutical (WST) in Q1 2025, closing a stake of 458 shares — an estimated $150K sold.

Eagle Bay Advisors first reported a position in WST in Q2 2021 and held it in 15 quarters. The position peaked at $407K in Q3 2023. 715 funds tracked by Wall St. Rank hold WST as of Q1 2025.

  • Eagle Bay Advisors reported no remaining West Pharmaceutical position as of Q1 2025 after selling out during the quarter.
  • Eagle Bay Advisors sold 458 West Pharmaceutical shares in Q1 2025, an estimated $150K.
  • Eagle Bay Advisors first reported a position in West Pharmaceutical in Q2 2021 and held it in 15 quarters.
  • Eagle Bay Advisors's West Pharmaceutical position peaked at $407K in Q3 2023.
  • 715 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2025.

Based on Eagle Bay Advisors's 13F filing for Q1 2025, filed 5 May 2025.